Schwartz, Jonathan2008-09-022008-09-022008-09-02https://hdl.handle.net/11299/42855The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.A positive rapid troponin I assay drawn during an episode of ACS is a reliable predictor of an adverse short-term, 30-day outcome, specifically death or MI. However, a negative rapid troponin I assay does not reliably indicate an absence of myocardial damage and predicts neither event-free short-term nor low-risk status of subsequent cardiac events. The event rate for patients with a negative rapid troponin I assay was 5.9% (132/2245 patients).en-USheart attackmyocardial infarctionacute coronary syndrometroponin IprognosisOther